GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allurion Technologies Inc (NYSE:ALUR) » Definitions » Short-Term Capital Lease Obligation

ALUR (Allurion Technologies) Short-Term Capital Lease Obligation : $0.83 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Allurion Technologies Short-Term Capital Lease Obligation?

Allurion Technologies's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.83 Mil.

Allurion Technologies's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 ($0.88 Mil) to Dec. 2024 ($0.87 Mil) and declined from Dec. 2024 ($0.87 Mil) to Mar. 2025 ($0.83 Mil).

Allurion Technologies's annual Short-Term Capital Lease Obligation increased from Dec. 2022 ($0.91 Mil) to Dec. 2023 ($0.91 Mil) but then declined from Dec. 2023 ($0.91 Mil) to Dec. 2024 ($0.87 Mil).


Allurion Technologies Short-Term Capital Lease Obligation Historical Data

The historical data trend for Allurion Technologies's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allurion Technologies Short-Term Capital Lease Obligation Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Short-Term Capital Lease Obligation
- 0.91 0.91 0.87

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.85 0.88 0.87 0.83

Allurion Technologies Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Allurion Technologies Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Allurion Technologies's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Allurion Technologies Business Description

Traded in Other Exchanges
N/A
Address
11 Huron Drive, Natick, MA, USA, 01760
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Executives
Shantanu Gaur director, officer: Chief Executive Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Omar Ishrak director 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Nicholas Sheridan Lewin director 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Krishna K. Gupta director, 10 percent owner 307 HARVARD ST, CAMBRIDGE MA 02139
Christopher J Geberth officer: Chief Financial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Michael R Davin director C/O CYNOSURE, INC., 5 CARLISLE ROAD, WESTFORD MA 01886
Larson Douglas Hudson director 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Benoit Chardon officer: Chief Commercial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Ram Chuttani officer: Chief Medical Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760